Dr. James Luyendyk is Professor of Pathobiology and Diagnostic Investigation at Michigan State University (MSU). His research team focuses on mechanisms of hepatotoxicity and liver repair/regeneration, with an emphasis on how components of the blood clotting system participate in acute liver injury and chronic liver disease. He has nearly 120 peer-reviewed publications, has co-edited the Hepatic Toxicology volume of Comprehensive Toxicology and co-authored the liver chapter in Casarett and Doull's Toxicology (8^th edition). Dr. Luyendyk is a Fellow of the Academy of Toxicological Sciences and is a recipient of numerous awards from the Society of Toxicology, including the Achievement Award. Dr. Luyendyk has served on numerous NIH Study Sections, including as standing member and Chairperson of XNDA. He holds diverse leadership roles in multiple professional societies, including as Co-chair of the new ISTH SSC on hemostatic management of patients with liver diseases, member of the AASLD hepatotoxicity special interest group steering committee, and as secretary and Council member of the Society of Toxicology.